Krystal begins phase III study of beremagene geperpavec for dystrophic epidermolysis bullosa July 29, 2020
Phase III Measure Up 2 study of Rinvoq in atopic dermatitis meets primary and secondary endpoints July 22, 2020
Arcutis begins phase IIb portion of phase I/IIb study of ARQ-252 for chronic hand eczema July 14, 2020
Cabaletta opens enrollment in phase I study of DSG3-CAART in mucosal-dominant pemphigus vulgaris July 7, 2020
RSS